Daniel A. González‐Padilla

Author

Hospital Universitario 12 De Octubre ORCID

Also Known As

D A González Padilla, D. Gonzalez Padilla, D. González-Padilla, D.A. Gonzalez Padilla, D.A. Gonzalez-Padilla, D.A. González Padilla, D.A. González-Padilla, Daniel A Gonzalez-Padilla, Daniel A González Padilla, Daniel A. Gonzalez Padilla

114

Publications

1.5K

Citations

H-Index

Concepts

All Affiliations

Hospital Universitario 12 De Octubre Research Institute Hospital 12 de Octubre Hospital Universitario La Paz Chinese University of Hong Kong Clinica Universidad de Navarra

About

Daniel A. González‐Padilla is an author at Hospital Universitario 12 De Octubre specializing in urology, medicine, and oncology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	6	6	303
2	Public Health	2	2	201
3	Biostatistics	1	1	27
4	Global Health	1	1	174
5	International Health	1	1	174

Daniel A. González‐Padilla

Publications

470

Citations

H-Index

Page 1

	Year	Citations
A Global Survey on the Impact of COVID-19 on Urological Services Jeremy Yuen‐Chun Teoh, William Ong Lay Keat, Daniel A. González‐Padilla, European Urology Urological ResearchUrologyContact TracingGlobal HealthGlobal Survey	2020	174
Recirculating hyperthermic intravesical chemotherapy with mitomycin C (HIVEC) versus BCG in high-risk non-muscle-invasive bladder cancer: results of the HIVEC-HR randomized clinical trial Félix Guerrero‐Ramos, Daniel A. González‐Padilla, Alejandro González-Díaz, World Journal of Urology	2022	59
Urinary Infections in Patients with Catheters in the Upper Urinary Tract: Microbiological Study A. Lara-Isla, José Medina‐Polo, Manuel Alonso-Isa, Urologia Internationalis	2017	38
Factors Influencing Intraoperative Blood Loss in Patients Undergoing Holmium Laser Enucleation of the Prostate (HoLEP) for Benign Prostatic Hyperplasia: A Large Multicenter Analysis Javier Otero, L. García-González, Borja García‐Gómez, Urology UrologyIntraoperative Blood LossLarge Multicenter AnalysisBenign Prostatic HyperplasiaSurgery	2019	36
Prospective study analyzing risk factors and characteristics of healthcare-associated infections in a Urology ward José Medina‐Polo, Raquel Sopeña Sutil, R. Benítez-Sala, Investigative and Clinical Urology	2017	29
Accuracy of the CUETO, EORTC 2016 and EAU 2021 scoring models and risk stratification tables to predict outcomes in high–grade non-muscle-invasive urothelial bladder cancer Wojciech Krajewski, Júlia Aumatell, José Daniel Subiela, Urologic Oncology Seminars and Original Investigations Prognostic EvaluationUrological ResearchUrologyEortc 2016Cancer Epidemiology	2022	27
Quality of life and adverse events in patients with nonmuscle invasive bladder cancer receiving adjuvant treatment with BCG, MMC, or chemohyperthermia Daniel A. González‐Padilla, Alejandro González-Díaz, Félix Guerrero‐Ramos, Urologic Oncology Seminars and Original Investigations Adverse EventsUrologySurgical OncologyGenitourinary CancerMedicine	2020	24
A global knowledge, attitudes and practices survey on anatomical endoscopic enucleation of prostate for benign prostatic hyperplasia among urologists Kalyan Gudaru, Daniel A. González‐Padilla, Daniele Castellani, Andrologia Urological ResearchUrologyPatient SafetyConventional Transurethral ResectionGlobal Knowledge	2020	23
Unlocking the Potential of Adequate Bacillus Calmette-Guérin Immunotherapy in Very-high-risk Non–muscle-invasive Bladder Carcinoma: A Multicenter Analysis of Oncological Outcomes and Risk Dynamics José Daniel Subiela, Wojciech Krajewski, Daniel A. González‐Padilla, European Urology Oncology Oncological OutcomesRisk DynamicsUrologyCancer RiskUrologic Cancer Epidemiology	2024	19
Assessment of the influence of transrectal and transperineal prostate biopsies on erectile function: A prospective observational single‐center study Esther García‐Rojo, Borja García‐Gómez, Daniel A. González‐Padilla, International Journal of Urology	2019	15

Page 1